Cargando…
Identification of myeloproliferative neoplasm drug agents via predictive simulation modeling: assessing responsiveness with micro-environment derived cytokines
Previous studies have shown that the bone marrow micro-environment supports the myeloproliferative neoplasms (MPN) phenotype including via the production of cytokines that can induce resistance to frontline MPN therapies. However, the mechanisms by which this occurs are poorly understood. Moreover,...
Autores principales: | Kobayashi, Susumu S., Vali, Shireen, Kumar, Ansu, Singh, Neeraj, Abbasi, Taher, Sayeski, Peter P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094977/ https://www.ncbi.nlm.nih.gov/pubmed/27056884 http://dx.doi.org/10.18632/oncotarget.8540 |
Ejemplares similares
-
Cytokines frequently implicated in myeloproliferative neoplasms
por: Wang, Yingying, et al.
Publicado: (2019) -
Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms
por: Hoermann, Gregor, et al.
Publicado: (2015) -
Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms
por: Pecquet, Christian, et al.
Publicado: (2023) -
Myeloproliferative neoplasms
por: Cross, Nick
Publicado: (2019) -
Myeloproliferative neoplasms
por: Kiladjian, Jean-Jacques
Publicado: (2018)